The global drug designing tools market is expected to grow from $ 1.77bn in 2018 to $5.15bn by 2028, expanding at a compound annual growth rate (CAGR) of 11.23% in terms of revenue during the 2018-2028 forecast period.

In a new report by Future Market Insights, the global drug designing tools market is tracked in terms of value and is calibrated to obtain the market revenue estimates. The adoption of advanced technologies in drug designing tools and increasing requirement of time- and cost-effective tools are increasing the growth of the drug designing tools market. However, infrastructure compatibility is a major problem faced by most organisations and is likely to challenge the revenue growth of the global drug designing tools market.

To understand and assess the demand and opportunities in the drug designing tools market, the report is categorically split into four major sections that focus on market analysis by solutions, by application, by end user and by region.

The market analysis by solutions section comprehensively analyses the market on the basis of multi-databases, virtual screening tools, structure designing/building tools, predictive analytics, model building tools, and other solutions in terms of value for the 2018-2028 period.

In 2018, the multi-databases segment dominated the drug designing tools market, followed by the virtual screening tools segment. The predictive analytics segment is projected to expand at the fastest CAGR of 13.22% over the forecast period in the drug designing tools market in terms of revenue, followed by the virtual screening tools segment.

The market analysis by application section analyses the various applications that use drug designing tools, and the data is provided in terms of value for the 2018-2028 period. The binding site prediction segment is expected to expand at a significant CAGR of 12.75% in terms of value during the forecast period.

In terms of market share, the docking segment accounted for a major percentage of the revenue share of the overall market in 2017, and is expected to dominate the drug designing tools market throughout the forecast years, followed by the target prediction segment.

The market analysis by end user section analyses various users that use tools in research and development (R&D), and the data is provided in terms of value for the 2018-2028 period. The contract research organisations (CRO) segment is expected to expand at a significant CAGR of 11.99% in terms of value during the forecast period.

In terms of market share, the pharmaceutical companies segment accounted for a major percentage of the revenue share of the overall market in 2017, and is expected to dominate the drug designing tools market throughout the forecast years, followed by the biotechnology companies segment.

The market analysis by region section includes an in-depth country-level analysis of the key regions including North America, Latin America, Western Europe, Eastern Europe, south-east Asia (SEA) of the Asia-Pacific (APAC), China, Japan, and the Middle East and Africa by product type, end-user and by country. It provides market data in terms of value for the 2018-2028 forecast period.

In 2018, the market in North America dominated the overall global drug designing tools market, followed by the market in Western Europe.

To request a sample report, click here.

To read a comprehensive overview, including a TOC, click here.